Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00661154 · ClinicalTrials.gov registry record
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 7
- Enrollment target
NCT00661154: Completed study, sponsored by Stanford University.
NCT00661154 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00661154 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
To determine whether using a radiolabelled analog of 5-FU, \[18F\]-5-fluorouracil, for PET/CT imaging can visually demonstrate differential chemotherapy delivery to known tumor sites before and after administration of bevacizumab and determine the optimal timing of bevacizumab administration to maximize the chemotherapy delivery into the tumor for improved cancer treatment.
Interventions
- DRUG Bevacizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00661154
The ClinicalTrials.gov registry entry for NCT00661154 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bevacizumab is the first listed.
NCT00661154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00661154 about?
NCT00661154 is a clinical study titled "Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project". To determine whether using a radiolabelled analog of 5-FU, \[18F\]-5-fluorouracil, for PET/CT imaging can visually demonstrate differential chemotherapy delivery to known tumor sites before and after administration of bevacizumab and determine the optimal timing of bevacizumab administration to maxi...
What is the current status of trial NCT00661154?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2008-02. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00661154?
The interventions under investigation include: Bevacizumab (DRUG).
Who is sponsoring clinical trial NCT00661154?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.